Company Filing History:
1 out of 460 
1 out of 1 
1 out of 832,843 Years Active: 2010
Title: Volker Dóring: Innovator in Nucleoside Production
Introduction
Volker Dóring is a notable inventor based in Paris, France. He has made significant contributions to the field of biochemistry, particularly in the production of nucleosides. His work has implications for antiviral and anticancer drug formulations.
Latest Patents
Dóring holds a patent for the "Production of 2'-deoxynucleosides and 2'-deoxynucleoside precursors from 2-dehydro-3-deoxy-D-gluconate." This invention relates to a process for preparing 2'-deoxynucleoside compounds or their precursors using 2-dehydro-3-deoxy-D-gluconic acid (KDG) or its salts as a starting material. A variety of 2'-deoxynucleosides and their analogues are utilized as starting materials for synthesis or drug formulation in the production of antiviral, anticancer, or antisense agents. Dóring has 1 patent to his name.
Career Highlights
Throughout his career, Volker Dóring has worked with several prominent companies, including Rhodia Chimie and Evologic S.A. He has also been associated with Marliere Technologies Société Civile. His experience in these organizations has contributed to his expertise in the field.
Collaborations
Dóring has collaborated with notable colleagues such as Denis Thibaut and Annett Kreimeyer. Their joint efforts have further advanced the research and development of nucleoside compounds.
Conclusion
Volker Dóring's innovative work in the production of nucleosides has made a significant impact in the field of biochemistry. His contributions continue to influence the development of important pharmaceutical agents.